ADHERENCE TO THE APPOINTMENT OF ANTICOAGULANT THERAPY WITH WARFARIN AND RIVAROXABAN IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATIONIN THE KYRGYZ REPUBLIC
Abstract
Purpose: to assess the adherence to treatment in elderly patients with nonvalvular atrial fibrillation who were prescribed anticoagulant therapy.Material and methods. During the study, 279 patients with atrial fibrillation of nonvalvular etiology were observed. Dependingon the type of anticoagulant taken, the patients were divided into 2 groups: the first group included 224 (80,3%) people who took warfarin, the second group - 55 (19,7%) people, who were prescribed a new oral anticoagulant - rivaroxaban.Results and discussion. By the end of the observation period, only 12% of patients in the first group and 32.7% of the secondgroup complied with the doctor's prescription. The vast majority of patients refused warfarin therapy due to the inability to control the international normalized ratio (INR). In the case of the appointment of rivaroxaban, the reason for the refusal to take was the high cost of the drug.Conclusions. Effective prevention of thromboembolic complications in atrial fibrillation requires the development of appropriate measures to improve patients’ adherence to treatment.
About the Author
B. . Kanat Kyzy
Кыргызская государственная медицинская академия имени И.К. Ахунбаева
Russian Federation
Russian Federation
References
1. Epidemiology of atrial fibrillation: European perspective / M. Zoni-Berisso [et al.] // Clin.Epidemiol. - 2014. - №6. - P. 213-220
2. Lippi, G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge / G. Lippi, F. Sanchis-Gomar, G. Cervellin // Int. J. Stroke. - 2021. - Vol. 16, №2. - P. 217-221
3. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis / A. Kishore [et al.] // Stroke. - 2014. - Vol. 45, №2. - P. 520-526
4. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society / C.T. January [et al.] // J. Am. Coll.Cardiol. - 2014. - Vol. 64, №21. -P. e1-76
5. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS / P. Kirchhof [et al.] // EP Europace. - 2016. - Vol. 18, №11. - P. 1609-1678
6. Анализ антитромботической терапии у пожилых людей во врачебной клинической практике центров семейной медицины Кыргызской Республики / К.К. Базира [и др.] // Тромбоз, гемостаз и реология. - 2021. - №1. - С. 40-47
7. Health literacy and warfarin therapy at two anticoagulation clinics in Brazil / M.A.P. Martins [et al.] // Heart. - 2017. - Vol. 103, №14. - P. 1089-1095
8. Rodriguez, R.A. Non adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation? / R.A. Rodriguez, M.Carrier, P.S. Wells // J. Thromb. Haemost.- 2013. - Vol. 11, №2. - P. 390-394
9. Reasons for warfarin discontinuation in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF) / E.C. O’Brien [et al.] // Am. Heart J. - 2014. - Vol. 168, №4. - P. 487-494
10. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants / V. Raparelli [et al.] // Thromb. Haemost. - 2017. - Vol. 117, №2. - P. 209-218
11. Pugh, D. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review / D. Pugh, J. Pugh, G.E. Mead. // Age Ageing. - 2011. - Vol. 40, №6. - Р. 675-683
Review
For citations:
Kanat Kyzy B. ADHERENCE TO THE APPOINTMENT OF ANTICOAGULANT THERAPY WITH WARFARIN AND RIVAROXABAN IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATIONIN THE KYRGYZ REPUBLIC. Bashkortostan Medical Journal. 2021;16(3):42-46. (In Russ.)
Views:
35
Email this article 
